Troy C. Sarich
Chief Commercial Data Science Officer @Johnson & Johnson Innovative Medicine
Signup · Get unlimited contacts
WORK HISTORY
Chief Commercial Data Science Officer @Johnson & Johnson Innovative Medicine
Raritan, NJ, US
Responsible for establishing and accelerating industry-leading commercial data, data science, RWE, precision medicine and digital capabilities for Janssen globally and continuing to drive growth for our $50+ Billion worldwide commercial pharmaceutical business. Collaborating with our commercial, technology and R&D leaders across the globe as we build our data science teams and capabilities and advance our go-to-market strategies. We are on the verge of realizing the true potential of advanced analytics, machine learning and AI solutions to have a direct impact on millions of patients and customers, where data science and precision medicine will be a key differentiator to our business growth in the coming years.
EDUCATION
The University of British Columbia
Ph.D., Department of Pharmacology & Therapeutics, Division of Clinical Pharmacology
Harvard Business School
J&J Strategic Leadership Program
Thompson Rivers University
Biology/Biological Sciences, General
The University of British Columbia
B.Sc., Department of Pharmacology & Therapeutics,
ABOUT TROY C. SARICH
Former J&J SVP, continuing to work at the intersection of pharmaceuticals, healthcare and AI to create the next wave of innovation that will have a direct impact on millions of patients around the world. Bringing decades of industry leadership experience in R&D through all phases of clinical development and in commercialization with advanced go-to-market and in-market strategies worldwide. Leveraging cutting edge expertise in advanced analytics, AI, precision medicine, digital health and RWE to be key differentiators to business growth and to have a positive impact on patients and healthcare systems. Most recently, Chief Commercial Data Science Officer, J&J Innovative Medicine, responsible for accelerating the growth of world-class global capabilities in Data, Data Science, RWE, Precision Medicine and Digital Health in order to strengthen the industry-leading commercial engine to grow the worldwide pharmaceutical business. Worked with experts around the globe to advance go-to-market strategies to reach even more patients. Realizing the true potential of advanced analytics, machine learning and AI solutions to have a direct impact on millions of patients, where Data, Data Science, RWE, Precision Medicine and Digital Health will be key differentiators in the coming years. Over 28 years in global healthcare I\'ve worked across multiple therapeutic areas in pharmaceutical R&D and commercial businesses. I\'ve led teams for major drug development programs like XARELTO® and INVOKANA® and across many aspects of the business including clinical development, RWE, data science, digital health, precision medicine, launches, market access, medical devices, start-up models and major business transformations. Proud recipient of the prestigious Johnson Medal Award as part of a XARELTO® team effort to bring this innovative medicine to millions of patients around the world through one of the largest clinical development programs in industry history. I continue to have the privilege of building and leading high-performing teams dedicated to improving the lives of patients. The views expressed on LinkedIn are my own.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.